Chemotherapy-Induced Peripheral Neuropathy (CIPN). Drug-induced polyneuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with chemotherapy-induced peripheral neuropathy
Exclusion criteria
Exclusion criteria: Entry into the study is subject to the absence of neuropathy due to other causes of neuropathy, including diabetes, radiculopathies, hereditary and acquired neuropathies, which can be verified at the beginning of the study through history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vascular Endothelial Growth Factor. Timepoint: Before and After the intervention. Method of measurement: Human VEGF Diagnostic Kit". | — |
Secondary
| Measure | Time frame |
|---|---|
| European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 score. Timepoint: Before and After the intervention. Method of measurement: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30.;6 minutes walking test score. Timepoint: Before and After the intervention. Method of measurement: 6 minutes walking test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Semnan University of Medical Sciences